Seeing Is Believing
Currently out of the existing stock ratings of David Steinberg, 131 are a BUY (84.52%), 23 are a HOLD (14.84%), 1 are a SELL (0.65%).
Analyst David Steinberg works with a stock forecast success ratio of 65.83% fulfilled within 242.33 days on average. Previously, David Steinberg worked at JEFFERIES.
David Steinberg’s has documented 280 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BHC, Bausch Health Companies at 20-Sep-2023.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) at 6/15/2020. The price target of $24 was fulfilled within 1 day with a profit of $0.93 (4.03%) receiving and performance score of 40.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 months 16 days ago
0/5 (0%)
$34.34 (396.54%)
Hold
3 months 27 days ago
0/2 (0%)
$21.59 (291.36%)
Hold
1.5
3 months 28 days ago
0/4 (0%)
$0.49 (48.51%)
Hold
1
$-0.34 (-25.37%)
2
4 months 20 days ago
1/4 (25%)
$0.06 (6.38%)
1
Hold
38
5 months 24 days ago
0/7 (0%)
$23.92 (169.89%)
What Year was the first public recommendation made by David Steinberg?